The store will not work correctly when cookies are disabled.
Sodium 1-chlorobenzo[h]isoquinoline-8-carboxylate
ID: ALA4848434
PubChem CID: 137464104
Max Phase: Preclinical
Molecular Formula: C14H7ClNNaO2
Molecular Weight: 257.68
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C([O-])c1ccc2c(ccc3ccnc(Cl)c32)c1.[Na+]
Standard InChI: InChI=1S/C14H8ClNO2.Na/c15-13-12-8(5-6-16-13)1-2-9-7-10(14(17)18)3-4-11(9)12;/h1-7H,(H,17,18);/q;+1/p-1
Standard InChI Key: ZGAMTELLVUVYFU-UHFFFAOYSA-M
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
46.0351 -13.2979 0.0000 Na 0 0 0 0 0 15 0 0 0 0 0 0
40.0698 -10.6482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0687 -11.4719 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.7809 -11.8808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7791 -10.2352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4918 -10.6446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4926 -11.4678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9088 -10.6377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1955 -10.2303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9135 -11.4640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2020 -11.8711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2019 -12.6896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9125 -13.1019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6248 -12.6856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6214 -11.8685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.3381 -13.0957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.3413 -13.9170 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
45.0484 -12.6803 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.7828 -12.6980 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 11 1 0
10 8 1 0
8 9 2 0
9 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 10 2 0
14 16 1 0
16 17 2 0
16 18 1 0
4 19 1 0
M CHG 2 1 1 18 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 257.68 | Molecular Weight (Monoisotopic): 257.0244 | AlogP: 3.74 | #Rotatable Bonds: 1 |
Polar Surface Area: 50.19 | Molecular Species: ACID | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.64 | CX Basic pKa: 1.07 | CX LogP: 3.22 | CX LogD: -0.11 |
Aromatic Rings: 3 | Heavy Atoms: 18 | QED Weighted: 0.53 | Np Likeness Score: -0.22 |
References
1. (2020) Anti-cancer/anti-fibrosis compounds, |